Abstract
Objective To investigate whether RNA interference could induce gene silencing in lung adenocarcinoma cells as well as assess the degree of vascular endothelial growth factor(VEGF) and angiopoietin2(Ang2) gene silencing and its effect on functional outcome. Methods Recombinant adenovirus AdVEGF shRNA and AdAng2 shRNA were constructed driving by H1 promoter targeted on VEGF and Ang2 utilizing gene recombinant technology.A549 cells was transfected with recombinant adenovirus.30 nude rats were randomly divided into 5 equal groups to be transplanted with AdVEGF shRNAA549 cells,AdAng2 shRNAA549 cells,AdVEGF shRNA add AdAng2 shRNAA549 cells;AdnullA549 cells and PBS only as blank control group.The growth of glioma was observed every five day.Thirty days Later, the rats were killed and the tumors were taken out to be examined.The tumor volume and weight were measured.The tumors were excised for immunohistochemistral staining of FⅧrelated antigen,VEGF,Ang2,PCNA and TUNEL.Results We successfully constructed recombinant adenovirus mediating AdVEGF shRNA and AdAng2 shRNA,the reproductive activity of the group transfected with AdVEGF shRNA and AdAng2 shRNA A549 cell was inhibited obviously.Comparing nontransfecting group and tranfecting AdNull group,they had significant difference(P< 0.01).The tumor volume and weight had statistical significance between the group treated by AdVEGF shRNA/AdAng2 shRNA or AdNull and PBS control group(P<0.01).Hemorrhage and lamellar necrosis were found in tumor treated by RNAi.Immunohistochemistral staining showed that the expression of Ang2 and VEGF protein significantly decreased in the cancer cell treated by RNAi and meanwhile microvessel density decreased too.It also showed that apoptosis increased and cell reproductive activity was inhibited in the cancer cell treated by RNAi.Conclusions VEGF and Ang2 may play an important role in lung adenocarcinoma progression.The specific small hairpin RNA targeting VEGF and Ang2 can inhibit the expression of VEGF and Ang2 protein and proliferation of lung adenocarcinoma cells in vitro and in vivo,the gene may become a target of gene therapy of lung adenocarcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have